Shares of Amryt Pharma plc (LON:AMYT – Get Free Report) passed below its fifty day moving average during trading on Tuesday . The stock has a fifty day moving average of GBX 143 ($1.78) and traded as low as GBX 143 ($1.78). Amryt Pharma shares last traded at GBX 143 ($1.78), with a volume of 90,727 shares changing hands.
Amryt Pharma Stock Performance
The company has a market capitalization of £457.11 million and a P/E ratio of -4.33. The firm has a 50 day moving average price of GBX 143 and a two-hundred day moving average price of GBX 143. The company has a debt-to-equity ratio of 66.05, a quick ratio of 1.14 and a current ratio of 1.80.
Amryt Pharma Company Profile
Amryt Pharma plc, a commercial-stage biopharmaceutical company, develops and commercializes novel therapeutics to treat patients suffering from serious and life-threatening rare diseases. The company offers Lomitapide for the treatment of homozygous familial hypercholesterolemia; and Metreleptin for the treatment of generalized and partial lipodystrophy.
See Also
- Five stocks we like better than Amryt Pharma
- What Do S&P 500 Stocks Tell Investors About the Market?
- Silicon Motion Proves That AI in Motion Stays in Motion
- How Technical Indicators Can Help You Find Oversold Stocks
- Undervalued UnitedHealth Group Won’t Be For Long
- Find and Profitably Trade Stocks at 52-Week Lows
- The 5 Stocks Most Sold By Insiders This Year
Receive News & Ratings for Amryt Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amryt Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
